SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-11-037897
Filing Date
2011-07-06
Accepted
2011-07-06 08:37:16
Documents
4
Period of Report
2011-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a11-16126_18k.htm 8-K 23744
2 EX-10.1 a11-16126_1ex10d1.htm EX-10.1 94220
3 EX-99.1 a11-16126_1ex99d1.htm EX-99.1 17340
4 GRAPHIC g161261mmi001.jpg GRAPHIC 3826
  Complete submission text file 0001104659-11-037897.txt   142123
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 11951686
SIC: 2835 In Vitro & In Vivo Diagnostic Substances